These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14084642)

  • 1. A REPORT ON THE USE OF COSALDON IN GENERAL PRACTICE.
    WALDRON DH
    Br J Clin Pract; 1963 Dec; 17():733-4. PubMed ID: 14084642
    [No Abstract]   [Full Text] [Related]  

  • 2. TREATMENT OF PARKINSONISM IN ELDERLY PATIENTS WITH COSALDON.
    MUSTARD DM
    Br J Clin Pract; 1964 Sep; 18():537-8. PubMed ID: 14207669
    [No Abstract]   [Full Text] [Related]  

  • 3. [REPORT ON THE SUBJECT OF RESULTS OBTAINED WITH COSALDON TREATMENT IN 35 PATIENTS OF THE INSTITUT NOTRE-DAME AT BRUGES-ST. MICHEL DURING THE PERIOD FROM JUNE TO DECEMBER, 1963].
    DUCHENE W
    Scalpel (Brux); 1964 Oct; 117():882-5. PubMed ID: 14230448
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of cosaldon in cerebral arteriosclerosis.
    FELSTEIN IL
    Br J Clin Pract; 1963 Aug; 17():448-9. PubMed ID: 13962885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cerebral arteriosclerosis with cosaldon].
    SPERLING R
    Med Klin; 1960 May; 55():845-7. PubMed ID: 13833290
    [No Abstract]   [Full Text] [Related]  

  • 6. A CONTROLLED TRIAL OF COSALDON IN ARTERIOSCLEROTIC DEMENTIA.
    COOPER AJ
    Br J Psychiatry; 1964 May; 110():415-8. PubMed ID: 14142534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cosaldon in the treatment of cerebral arteriosclerosis].
    Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
    Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
    EHLERS G
    Munch Med Wochenschr; 1959 Aug; 101():1355-7. PubMed ID: 13819571
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral sclerosis and its treatment with cosaldon].
    MEYER J
    Med Klin; 1957 Jun; 52(24):1073-4. PubMed ID: 13451071
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement of brain circulation with cosaldon as a therapeutic measure in pediatrics].
    HERBST R
    Munch Med Wochenschr; 1962 Jun; 104():1184-6. PubMed ID: 13906651
    [No Abstract]   [Full Text] [Related]  

  • 12. [LONG-TERM THERAPY WITH COSALDON IN BLOOD CIRCULATION DISORDERS OF THE RETINA AND CHOROID].
    NEUBAUER H
    Klin Monbl Augenheilkd; 1965 Jun; 146():646-65. PubMed ID: 14315871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with Cosaldon retard in double blind studies].
    Dreyer H; Keussen M; Wojtek L
    Dtsch Med J; 1969 May; 20(10):356-8. PubMed ID: 4919479
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of arteriosclerotic retinopathy with Cosaldon A+E (author's transl)].
    Zielinski HW
    Klin Monbl Augenheilkd; 1978 Dec; 173(6):857-64. PubMed ID: 732204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cosaldon opens blood-brain barrier].
    Z Allgemeinmed; 1971 Sep; 47(25):1294-6. PubMed ID: 5110506
    [No Abstract]   [Full Text] [Related]  

  • 16. [On Cosaldin and psychic functions in the elderly. Criticism of the method used in a psychopharmacological study].
    GRUVSTAD M
    Sven Lakartidn; 1963 Apr; 60():1100-5. PubMed ID: 13950970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cosaldon retard in the treatment of certain maculopathies (author's transl)].
    Starzycka M; Krukar-Bastrowa K
    Klin Oczna; 1980 Jun; 82(6):315-6. PubMed ID: 7406972
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Cosaldin the capacity for orientation, memory and thinking in elderly patients with cerebral arteriosclerosis].
    BJURWILL B
    Sven Lakartidn; 1963 Jan; 60():192-9. PubMed ID: 13971348
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON ELECTRORHEOGRAPHIC OBJECTIVE EVALUATION OF SUBSTANCES WITH CENTRAL NERVOUS SYSTEM ACTION. SODIUM NICOTINATE AND SODIUM BETA,BETA-PENTAMETHYLENE-GAMMA-HYDROXYBUTYRATE MONOHYDRATE].
    KUNERT W; DUNKER R
    Arzneimittelforschung; 1963 Nov; 13():986-8. PubMed ID: 14210439
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of Cosaldon retard in ophthalmological practice (author's transl)].
    Hasslinger C
    Klin Monbl Augenheilkd; 1973 Dec; 163(6):755-60. PubMed ID: 4788875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.